{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:10:01Z","timestamp":1791155401719,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003256","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000}}],"reference-count":78,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003256.pub2","type":"journal-article","created":{"date-parts":[[2014,8,31]],"date-time":"2014-08-31T19:17:26Z","timestamp":1409512646000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults"],"prefix":"10.1002","volume":"2014","author":[{"given":"Oluwatoyin F","family":"Gbabe","sequence":"first","affiliation":[{"name":"Stellenbosch University; Community Health Division, Faculty of Medicine and Health Sciences; Francie van Zijl Drive Tygerberg Cape Town South Africa 7505"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles I","family":"Okwundu","sequence":"additional","affiliation":[{"name":"Stellenbosch University; Centre for Evidence-based Health Care, Faculty of Medicine and Health Sciences; Francie van Zijl Drive Tygerberg Cape Town South Africa 7505"},{"name":"South African Medical Research Council; South African Cochrane Centre; PO Box 19070 Tygerberg Western Cape South Africa 7505"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dedicoat","sequence":"additional","affiliation":[{"name":"Birmingham Heartlands Hospital; Department of Infection; Bordesley Green East Birmingham UK B9 5SS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther E","family":"Freeman","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital; Department of Dermatology; Boston Massachusetts USA 02115"},{"name":"Harvard Medical School; Department of Dermatology; Boston Massachusetts USA 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,9,1]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD003256.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.2013.51.6757","article-title":"Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma","volume":"32","author":"Bower","year":"2014","journal-title":"Journal of Clinical Oncology"},{"issue":"13","key":"10.1002\/14651858.CD003256.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/QAD.0b013e32832d080d","article-title":"The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma","volume":"23","author":"Bower","year":"2009","journal-title":"AIDS"},{"issue":"10","key":"10.1002\/14651858.CD003256.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/QAD.0b013e328360a5a1","article-title":"Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK","volume":"27","author":"Letang","year":"2013","journal-title":"AIDS"},{"issue":"16","key":"10.1002\/14651858.CD003256.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1002\/cncr.25362","article-title":"Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy","volume":"116","author":"Cianfrocca","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD003256.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1634\/theoncologist.12-1-114","article-title":"A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma","volume":"12","author":"Cooley","year":"2007","journal-title":"The Oncologist"},{"issue":"8","key":"10.1002\/14651858.CD003256.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1200\/JCO.1996.14.8.2353","article-title":"Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma","volume":"14","author":"Gill","year":"1996","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003256.pub2-BIB0007|cit7","first-page":"13","article-title":"Liposomal doxorubicin in pulmonary Kaposi's sarcoma: improved survival as compared to patients without liposomal doxorubicin","volume":"21","author":"Gr\u00fcnaug","year":"1998","journal-title":"European Journal of Medical Research"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0008|cit8","first-page":"44","article-title":"Systemic treatment modalities in the management of AIDS-related Kaposi's sarcoma","volume":"9","author":"Hernandez","year":"1997","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"12","key":"10.1002\/14651858.CD003256.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1097\/01.aids.0000131385.60974.b9","article-title":"Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma","volume":"18","author":"Martin-Carbonero","year":"2004","journal-title":"AIDS (London, England)"},{"issue":"10","key":"10.1002\/14651858.CD003256.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/QAD.0b013e328182df03","article-title":"Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART\/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma","volume":"21","author":"Bihl","year":"2007","journal-title":"AIDS (London, England)"},{"issue":"2","key":"10.1002\/14651858.CD003256.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/QAI.0b013e318251aedd","article-title":"A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa","volume":"60","author":"Mosam","year":"2012","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/ijc.20606","article-title":"Treatment of AIDS-associated Kaposi\u2019s sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial","volume":"113","author":"Olweny","year":"2005","journal-title":"International Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003256.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1468-1293.2011.00955.x","article-title":"Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda","volume":"13","author":"Asiimwe","year":"2012","journal-title":"HIV Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003256.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1365-2133.2005.06452.x","article-title":"Docetaxel in anthracycline-pretreated AIDS-related Kaposi's sarcoma: a retrospective study","volume":"152","author":"Autier","year":"2005","journal-title":"British Journal of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD003256.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/QAD.0b013e328182df03","article-title":"Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART\/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma","volume":"21","author":"Bihl","year":"2007","journal-title":"AIDS (London, England)"},{"issue":"2","key":"10.1002\/14651858.CD003256.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00128071-200102020-00004","article-title":"Phase III vehicle controlled multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS related Kaposi's sarcoma","volume":"2","author":"Bodsworth","year":"2001","journal-title":"American Journal of Clinical Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003256.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.annonc.a057916","article-title":"Topical treatment of epidemic Kaposi's sarcoma with all-trans-retinoic acid","volume":"2","author":"Bonhomme","year":"1991","journal-title":"Annals of Oncology"},{"issue":"19","key":"10.1002\/14651858.CD003256.pub2-BIB0018|cit18","first-page":"2417","article-title":"Treatment of AIDS-associated Kaposi's sarcoma with oral tretinoin","volume":"51","author":"Bonhomme","year":"1994","journal-title":"American Journal of Hospital Pharmacy"},{"issue":"3","key":"10.1002\/14651858.CD003256.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/654800","article-title":"Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe","volume":"51","author":"Borok","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD003256.pub2-BIB0020|cit20","first-page":"779","article-title":"Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy","volume":"27","author":"Cattelan","year":"2005","journal-title":"International Journal of Oncology"},{"issue":"12","key":"10.1002\/14651858.CD003256.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/archderm.136.12.1461","article-title":"Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials","volume":"136","author":"Duvic","year":"2000","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0002-9343(87)90445-1","article-title":"Combination chemotherapy of disseminated Kaposi\u2019s sarcoma in patients with the acquired immune deficiency syndrome","volume":"62","author":"Gelmann","year":"1987","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0002-9343(91)80081-V","article-title":"Systemic treatment of AIDS related Kaposi's sarcoma: results of a randomized trial","volume":"90","author":"Gill","year":"1991","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003256.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-8140(97)00141-2","article-title":"Response and cosmetic outcome of two fractionation regimens for AIDS related Kaposi's sarcoma","volume":"46","author":"Harrison","year":"1998","journal-title":"Radiotherapy and Oncology"},{"issue":"11","key":"10.1002\/14651858.CD003256.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-4362.1996.tb02990.x","article-title":"Advanced epidemic Kaposi's sarcoma: treatment with bleomycin or combination of doxorubicin, bleomycin, and vincristine","volume":"35","author":"Hernandez","year":"1996","journal-title":"International Journal of Dermatology"},{"issue":"2 Suppl 5","key":"10.1002\/14651858.CD003256.pub2-BIB0026|cit26","first-page":"32-6; discussio","article-title":"Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma using bleomycin-containing combination chemotherapy regimens","volume":"19","author":"Ireland-Gill","year":"1992","journal-title":"Seminars in Oncology"},{"issue":"1","key":"10.1002\/14651858.CD003256.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/QAI.0b013e3181fc0141","article-title":"Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma","volume":"56","author":"Koon","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"4","key":"10.1002\/14651858.CD003256.pub2-BIB0028|cit28","first-page":"359","article-title":"Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposide","volume":"7","author":"Krigel","year":"1988","journal-title":"Journal of Biological Response Modifiers"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/0003-4819-111-1-41","article-title":"Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi's sarcoma","volume":"111","author":"Lane","year":"1989","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003256.pub2-BIB0030|cit30","first-page":"483","article-title":"Kaposi sarcoma in HIV patients: response to antiretroviral treatment and chemotherapy","volume":"131","author":"Lasso","year":"2003","journal-title":"Revista Medica de Chile"},{"issue":"10","key":"10.1002\/14651858.CD003256.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/QAD.0b013e328360a5a1","article-title":"Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK","volume":"27","author":"Letang","year":"2013","journal-title":"AIDS"},{"issue":"3","key":"10.1002\/14651858.CD003256.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s15010-005-4099-z","article-title":"Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery","volume":"33","author":"Lichterfeld","year":"2005","journal-title":"Infection"},{"issue":"2","key":"10.1002\/14651858.CD003256.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/cncr.20780","article-title":"Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma","volume":"103","author":"Lim","year":"2005","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/14651858.CD003256.pub2-BIB0034|cit34","first-page":"206","article-title":"Regression of AIDS-related Kaposi's sarcoma following combined antiretroviral treatment","volume":"32","author":"Monticelli","year":"2000","journal-title":"Revista Argentina de Microbiologia"},{"issue":"18","key":"10.1002\/14651858.CD003256.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1097\/QAD.0b013e328314b5f1","article-title":"Patients presenting with AIDS in the HAART era: a collaborative cohort analysis","volume":"22","author":"Mussini","journal-title":"AIDS"},{"issue":"8","key":"10.1002\/14651858.CD003256.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/QAD.0b013e3282ff6275","article-title":"Persistent Kaposi sarcoma in the era of HAART: characterizing the predictors of clinical response","volume":"22","author":"Nguyen","year":"2008","journal-title":"AIDS"},{"issue":"7","key":"10.1002\/14651858.CD003256.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.1998.16.7.2445","article-title":"Pegylated liposomal doxorubicin versus doxorubicin, bleomycin and vincristine in the treatment of AIDS related Kaposi's sarcoma: results of a randomised phase III clinical trial","volume":"16","author":"Northfelt","year":"1998","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD003256.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1200\/JCO.2005.11.043","article-title":"Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team","volume":"23","author":"Noy","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD003256.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1310\/700B-9QT3-HGN9-Q3FQ","article-title":"Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy","volume":"2","author":"Nunez","year":"2001","journal-title":"HIV Clinical Trials"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1258\/0956462991914285","article-title":"A randomized trial of interferon a2a and zidovudine versus bleomycin and zidovudine for AIDS related Kaposis sarcoma. Swiss HIV Cohort Study","volume":"10","author":"Opravil","year":"1999","journal-title":"International Journal of STD and AIDS"},{"issue":"6","key":"10.1002\/14651858.CD003256.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1081\/CNV-100104284","article-title":"Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma: a randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine","volume":"19","author":"Osoba","year":"2001","journal-title":"Cancer Investigation"},{"issue":"5","key":"10.1002\/14651858.CD003256.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1468-1293.2006.00378.x","article-title":"Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy","volume":"7","author":"Palmieri","year":"2006","journal-title":"HIV Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003256.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1368-8375(01)00100-2","article-title":"Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial","volume":"38","author":"Ramirez-Amador","year":"2002","journal-title":"Oral Oncology"},{"issue":"1","key":"10.1002\/14651858.CD003256.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00000421-200202000-00012","article-title":"Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma","volume":"25","author":"Rosenthal","year":"2002","journal-title":"American Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD003256.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1998.16.5.1736","article-title":"Prospective randomized trial of two dose levels of interferon alpha with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection. A Canadian HIV clinical trials network study","volume":"16","author":"Shepherd","year":"1998","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD003256.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2008.03.009","article-title":"Hypofractionated radiation therapy in the treatment of epidemic Kaposi sarcoma--a prospective randomized trial","volume":"88","author":"Singh","year":"2008","journal-title":"Radiotherapy and Oncology"},{"issue":"5","key":"10.1002\/14651858.CD003256.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0360-3016(93)90523-X","article-title":"A randomized prospective trial of radiation therapy for AIDS-associated Kaposi's sarcoma","volume":"27","author":"Stelzer","year":"1993","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"2","key":"10.1002\/14651858.CD003256.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.1998.16.2.683","article-title":"Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma","volume":"16","author":"Stewart","year":"1998","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD003256.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000292356","article-title":"Retrospective analysis of the efficacy of gemcitabine for previously treated AIDS-associated Kaposi's sarcoma in western Kenya","volume":"78","author":"Strother","year":"2010","journal-title":"Oncology"},{"issue":"10","key":"10.1002\/14651858.CD003256.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2117::AID-CNCR23>3.0.CO;2-X","article-title":"Combination chemotherapy with doxorubicin, bleomycin, and vindesine for AIDS-related Kaposi's sarcoma","volume":"77","author":"Tavio","year":"1996","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD003256.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/cncr.10634","article-title":"Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma","volume":"95","author":"Tulpule","year":"2002","journal-title":"Cancer"},{"issue":"5","key":"10.1002\/14651858.CD003256.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00002030-199605000-00010","article-title":"Randomized cross-over comparison of liposomal daunorubicin versus observation for early Kaposi's sarcoma","volume":"10","author":"Uthayakumar","year":"1996","journal-title":"AIDS (London, England)"},{"issue":"3","key":"10.1002\/14651858.CD003256.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00042560-199911010-00004","article-title":"Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group","volume":"22","author":"Walmsley","year":"1999","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"3","key":"10.1002\/14651858.CD003256.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00432-011-1109-7","article-title":"Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi's sarcoma","volume":"138","author":"Zhong","year":"2012","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD003256.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.qco.0000200295.30285.13","article-title":"AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy","volume":"19","author":"Bower","year":"2006","journal-title":"Current Opinion in Infectious Diseases"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1182\/blood.V84.8.2711.2711","article-title":"Identification and culture of Kaposi\u2019s sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls","volume":"84","author":"Browning","year":"1994","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD003256.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ijc.10790","article-title":"Reduced incidence of Kaposi's sarcoma and of systemic non-Hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy","volume":"103","author":"Carrieri","year":"2003","journal-title":"International Journal of Cancer"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-med-050409-103711","article-title":"The\u00a0increasing\u00a0burden\u00a0of\u00a0HIV-associated\u00a0malignancies\u00a0in\u00a0resource-limited\u00a0regions","volume":"62","author":"Casper","year":"2011","journal-title":"Annual Review of Medicine"},{"issue":"5192","key":"10.1002\/14651858.CD003256.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of new human herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0060|cit60","unstructured":"Cochrane HIV\/AIDS Group About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2011, Issue 1. Art. No.: HIV"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/jnci\/89.24.1868","article-title":"Expression of human herpesvirus 8-encoded cyclin D in Kaposi\u2019s sarcoma spindle cells","volume":"89","author":"Davis","year":"1997","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1002\/14651858.CD003256.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(07)70036-0","article-title":"Management of AIDS-related Kaposi's sarcoma","volume":"8","author":"Lorenzo","year":"2007","journal-title":"The Lancet Oncology"},{"issue":"2","key":"10.1002\/14651858.CD003256.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/039463200601900202","article-title":"Role of pegylated lyposomal doxorubicin (PLD) in systemic Kaposi's sarcoma: a systematic review","volume":"19","author":"Trolio","year":"2006","journal-title":"International Journal of Immunopathology and Pharmacology"},{"issue":"12","key":"10.1002\/14651858.CD003256.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980-2002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0065|cit65","unstructured":"Freeman E Semeere A Wenger M Mwebesa B Asirwa FC Busakhala N Pitfalls of Practicing Cancer Epidemiology in resource-limited settings: The case of survival after a diagnosis with Kaposi\u2019s sarcoma in sub-Saharan Africa 14th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies November 2013"},{"issue":"5","key":"10.1002\/14651858.CD003256.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/pbc.22369","article-title":"Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children","volume":"54","author":"Gantt","year":"2010","journal-title":"Pediatric Blood Cancer"},{"issue":"5","key":"10.1002\/14651858.CD003256.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00002030-200103300-00013","article-title":"Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy","volume":"15","author":"Grulich","year":"2001","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0068|cit68","unstructured":"Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00126334-200007010-00013","article-title":"Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy","volume":"24","author":"Jones","year":"2000","journal-title":"Journal of Acquired Immune Deficiency Syndrome"},{"issue":"4","key":"10.1002\/14651858.CD003256.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00042560-200004010-00017","article-title":"Development of Kaposi sarcoma despite sustained suppression of HIV plasma viremia","volume":"23","author":"Khanlou","year":"2000","journal-title":"Journal of Acquired Immune Deficiency Syndrome"},{"issue":"9","key":"10.1002\/14651858.CD003256.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.1989.7.9.1201","article-title":"Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee","volume":"7","author":"Krown","year":"1989","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0072|cit72","unstructured":"Krown SE Clinical characteristics of Kaposi sarcoma HIV InSite Knowledge Base Chapter February 2006"},{"issue":"6","key":"10.1002\/14651858.CD003256.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/157016209789973619","article-title":"AIDS-related\u00a0Kaposi's\u00a0sarcoma: state of the art and therapeutic strategies","volume":"7","author":"Martellotta","year":"2009","journal-title":"Current HIV Research\u00a0"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0074|cit74","unstructured":"Martin J Laker-Oketta M Walusana V Orem J Wabinga H Bennett J Antiretrovirals for Kaposi\u2019s Sarcoma (ARKS): A randomized trial of protease inhibitor-based antiretroviral therapy for AIDS-associated Kaposi\u2019s sarcoma in sub-Saharan Africa 14th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies November 2013"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1056\/NEJMc070508","article-title":"HIV-Associated Kaposi's Sarcoma with a High CD4 Count and a Low Viral Load","volume":"357","author":"Maurer","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003256.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"2644\u201354","DOI":"10.1002\/cncr.20309","article-title":"The changing pattern of Kaposi sarcoma in patients with HIV, 1994\u20132003: the EuroSIDA Study","volume":"100","author":"Mocroft","year":"2004","journal-title":"Cancer"},{"issue":"5","key":"10.1002\/14651858.CD003256.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/CCO.0b013e328355e14b","article-title":"Impact of Antiretroviral Therapy on the Incidence of Kaposi\u2019s Sarcoma in Resource-rich and Resource-limited Settings","volume":"24","author":"Semeere","year":"2012","journal-title":"Current opinion in oncology"},{"issue":"3","key":"10.1002\/14651858.CD003256.pub2-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003256","article-title":"Treatment of Kaposis sarcoma in HIV-1 infected individuals with emphasis on resource poor settings","author":"Dedicoat","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003256.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T17:17:34Z","timestamp":1720631854000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003256.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane HIV\/AIDS Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,1]]},"references-count":78,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003256.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,1]]}}}